These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28498414)

  • 21. Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide.
    Long J; Zhou B; Li H; Dai Q; Zhang B; Xing S; Zeng Z; Chen W; Yang J
    Immunol Invest; 2013; 42(2):137-55. PubMed ID: 23323523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.
    Venturelli S; Armeanu S; Pathil A; Hsieh CJ; Weiss TS; Vonthein R; Wehrmann M; Gregor M; Lauer UM; Bitzer M
    Cancer; 2007 May; 109(10):2132-41. PubMed ID: 17407132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine.
    Iinuma T; Homma S; Noda T; Kufe D; Ohno T; Toda G
    J Clin Invest; 2004 May; 113(9):1307-17. PubMed ID: 15124022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.
    Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX
    Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.
    Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y
    Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T; Sumimoto H; Kawamura N; Ueda R; Takahashi T; Mizuguchi H; Miyagishi M; Takeda K; Kawakami Y
    J Immunol; 2011 Jul; 187(1):27-36. PubMed ID: 21632716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
    Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
    Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
    Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
    Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell vaccine in addition to FOLFIRI regimen improve antitumor effects through the inhibition of immunosuppressive cells in murine colorectal cancer model.
    Kim HS; Park HM; Park JS; Sohn HJ; Kim SG; Kim HJ; Oh ST; Kim TG
    Vaccine; 2010 Nov; 28(49):7787-96. PubMed ID: 20883737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
    Liu Y; Huang H; Chen Z; Zong L; Xiang J
    J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
    Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy enhances antitumor immune responses induced by irradiated hepatocellular carcinoma cells engineered to express hepatitis B virus X protein.
    Yan Y; Liu N; Lu L; Zang CM; Shao B; Li Y; Wen Y; Wei Y; Cheng P
    Oncol Rep; 2013 Aug; 30(2):993-9. PubMed ID: 23754319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.
    Ge C; Xing Y; Wang Q; Xiao W; Lu Y; Hu X; Gao Z; Xu M; Ma Y; Cao R; Liu J
    Int Immunopharmacol; 2011 Dec; 11(12):2200-7. PubMed ID: 22015603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity.
    Tai WT; Shiau CW; Li YS; Chang CW; Huang JW; Hsueh TT; Yu HC; Chen KF
    J Hepatol; 2014 Jul; 61(1):89-97. PubMed ID: 24657398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice.
    DeMatos P; Abdel-Wahab Z; Vervaert C; Seigler HF
    Cell Immunol; 1998 Apr; 185(1):65-74. PubMed ID: 9636684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection.
    Herbert N; Haferkamp A; Schmitz-Winnenthal HF; Zöller M
    J Immunol; 2010 Jul; 185(2):902-16. PubMed ID: 20548033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.